Efficacy of glutathione in the treatment of viral hepatitis
Mingxi Bao
Abstract
Mingxi Bao
Abstract
Objective:To observe the efficacy and safety of glutathione in the treatment of viral hepatitis.Methods:In the series,106 patients with viral hepatitis were randomly divided into groups A and B.Patients in group A received glutathione for four weeks,patient in group B received potassium magnesium aspartate for four weeks.Results:In Group A,at the end of treatment,the effective rate for tired and anorexia in patients with actue hepatitis were94.4% and 88.9%,respectively,in patients with chronic hepatitis were 88.7%,85.7%,which were significantly higher than that in group B(P0.05).STB,SCB,TBA,ALT and AST were lower in group A than in group B(P0.05).The increase of albumin after treatment was more significant in group A than in group B(P0.05).Conclusion:Glutathione has better efficacy than potassium magnesium aspartate in the treatment of patients with viral hepatitis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the efficacy and safety of glutathione in the treatment of viral hepatitis.Methods:In the series,106 patients with viral hepatitis were randomly divided into groups A and B.Patients in group A received glutathione for four weeks,patient in group B received potassium magnesium aspartate for four weeks.Results:In Group A,at the end of treatment,the effective rate for tired and anorexia in patients with actue hepatitis were94.4% and 88.9%,respectively,in patients with chronic hepatitis were 88.7%,85.7%,which were significantly higher than that in group B(P0.05).STB,SCB,TBA,ALT and AST were lower in group A than in group B(P0.05).The increase of albumin after treatment was more significant in group A than in group B(P0.05).Conclusion:Glutathione has better efficacy than potassium magnesium aspartate in the treatment of patients with viral hepatitis.
Key concepts: Glutathione, Medicine, Internal medicine, Gastroenterology, Anorexia, Viral hepatitis, Group A, Group B